Status:
COMPLETED
Effect of Intrapulpal Injections on the Post-endodontic Pain
Lead Sponsor:
Jamia Millia Islamia
Conditions:
Pulpitis - Irreversible
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
To achieve painless treatment in patients with a failed primary IANB, supplementary anesthesia has been advised. The majority of the studies evaluating intrapulpal injections have been performed on as...
Eligibility Criteria
Inclusion
- Symptomatic carious exposed mandibular first or second molars.
- Positive and prolonged response to thermal sensitivity tests and electric pulp tests.
- Vital coronal pulp on access cavity preparation.
- American Society of Anesthesiologists class I or II medical history.
- Ability to understand the use of pain scales.
Exclusion
- Active pain in more than 1 tooth.
- Teeth with fused roots.
- Radiographic evidence of an extra root.
- Large restorations with overhanging margins.
- Full crowns or deep periodontal pockets.
- Known allergy or contraindications to any content of the local anesthetic solution or NSAIDs
- History of known or suspected drug abuse.
- Taking any drugs which could affect the pain perception, e.g, opiods, antidepressants, anticonvulsants, muscle relaxants, anxiolytics, sedatives, nsaids. 23
- Pregnant or breastfeeding patients.
- Patients with asthma, gastric ulcers, and bleeding disorders.
Key Trial Info
Start Date :
July 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06088446
Start Date
July 5 2023
End Date
October 3 2023
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Jamia MIliia Islamia
New Delhi, India, 110025